Transfer of Antisense Oligodeoxynucleotides Against

ODN Transfer
Cells were washed 3 times with Hanks' balanced saline solution (HBSS) after they grew to 90% confluence. dpGapoE was mixed with ODNs at a weight ratio of 53/4 (dpGapoE/ODN) in sterile, distilled water using a micromixer. 6 The mixtures were allowed to stand at room temperature for 30 min. After being mixed with medium at a final ODN concentration of 0.1 mol/L, the mixtures were added to the culture dishes. After being transfected for 2 h at 37°C, the cells were washed twice with medium and incubated with medium for 48 h. Cells that were incubated with medium but without ODNs or dpGapoE were used as controls. The data of triplicate experiments are shown.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from homogenized tissue with an RNAzol B kit (Tel Test Inc, TX, USA). RT-PCR was performed using HCEC RNA and primers designed to amplify transcripts of ETB and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). RT reaction was performed using the GeneAmp™ kit (Perkin Elmer Cetus). Three sets of primers were used: ETA receptor gene: sense 5'-ACC ACT TTT CGT GGC ACA G-3' and antisense 5'-TGC TCT GTA CCT GTC AAC AC-3'; ETB receptor gene: sense 5'-AGG TGC CTA AAG GAG ACA G-3' and antisense 5'-AGA CTC AGC ACA GTG ATT C-3'; and GAPDH: sense 5'-CTG CAC CAC CAA CTG CTT AG-3' and antisense 5'-ACC ACC TG TTG CTG TAG CC-3'. The amount of PCR product from ETA, ETB receptors and GAPDH mRNAs increased linearly from 27 to 33, 30 to 36 and 21 to 27 PCR cycles, respectively. PCR therefore was performed for 30 cycles for ETA, 33 cycles for ETB and 24 cycles for GAPDH with the following cycle profile: denaturing at 94°C for 1 min, annealing at 52°C for 2 min, and extension at 72°C for 4 min. PCR products were analyzed on 1.0% agarose gel. The ratio of the amount of ETA or ETB mRNA to that of GAPDH mRNA was evaluated by densitometric analysis.
Results
ET Receptor Isoform Expression in HCECs and HCSMCs
Using RT-PCR, we investigated ET receptor isoforms in HCSMCs and HCECs. Although both ETA and ETB receptors were expressed in HCSMCs, only ETB receptors were expressed in HCECs (data not shown).
Translocation of FITC-ODNs Into the Cell Nucleus
FITC-labelled phosphorothioated ODNs were used to investigate the ability of dpGapoE to deliver FITC-ETA-ASODNs to HCSMCs and FITC-ETB-AS-ODNs to HCECs. In a control experiment in which HCSMCs and HCECs were incubated with 10 mol/L FITC-ODNs, fluorescence microscopy revealed only weak cell-associated fluorescence. In contrast, 40±3 (mean ± SEM)% of HCSMCs (n=3) and 60±4% of HCECs (n=3) that were incubated for 48 h after transfection showed a fluorescent nucleus (Fig 1A,B) .
Effects of ODNs on ET Receptor mRNA
After ODNs for the ETA receptor were transferred to HCSMCs, the cellular ETA receptor mRNA concentration was assessed by RT-PCR. Transfection with AS-ODNs for ETA receptor decreased ETA receptor mRNA (Fig 2, upper panel, lane 4) compared with that in the control (lanes 1, 2), whereas transfection with S-ODNs for ETA receptor did not change ETA receptor mRNA (Fig 2, lane 3) . Similar results were observed with the transfer of ODNs for ETB receptor to HCECs (Fig 2, lower panel) . AS-ODNs for ETB receptor decreased ETB receptor mRNA (Fig 2, lower  panel, lane 4) . Densitometric analysis demonstrated that AS-ODNs decreased the ratio of the level of GAPDH mRNA to ETA or ETB mRNA to approximately 20% of the control value obtained with S-ODNs.
Discussion
AS-ODNs are a new generation of putative therapeutic agents. 2 Although they have been delivered by various techniques, including microinjection, electroporation, viral transfection, lipofection and receptor-mediated endocytosis, there are various problems with their use, including complex manipulation, cellular toxicity, and immunogenicity. Because many lipoprotein receptors and their ligands have been well characterized, we selected dpGapoE, which covers the entire putative low density lipoprotein receptorbinding site of apoE (amino acid residues 129-169). 5 The present results show that dpGapoE was highly effective for the transfer of AS-ODNs into cells: approximately 40-60% of the cells exhibited a dense fluorescent nucleic acid delivery system, and there was efficient release of ODNs from the liposome and efficient dissociation of ODNs from the complex into cytoplasm, after which the ODNs migrated into the nucleus.
Each AS-ODN selectively inhibited ETA and ETB receptor expression. Interaction between the AS-ODNs and the mRNA of a specific receptor had an inhibitory effect because of the reduced number of available receptors. The use of competitive antagonists for receptors has other advantages, but often their specificity is concentrationdependent and antagonists are not yet available for some receptors. In the case of ET receptors, Adner et al showed the attenuation of ET-1-induced contraction in circular segments of the human superficial temporal artery incubated with 1 mol/L of ETA-AS-ODNs. 8 ETA receptors on SMCs are mainly responsible for constriction throughout the human vasculature, including the coronary artery; the situation in animals is more complex because the relative contribution from activating the constrictor ETB receptor can vary, depending on the species and vascular bed. Therefore, using the dpGapoE-AS-ODN complex for local gene delivery by coronary catheterization may enable gene regulation in vivo, which could be useful for regulating coronary artery vascular tone and constriction.
